Chronic News and Research

RSS

Home treatment improves chronic constipation in children

Home treatment with a simple, battery-operated system that applies four sticky electrode patches to the mid-section allowed a group of children with the most difficult-to-treat, possibly congenital, constipation to reduce soiling and improve elimination, according to results presented today at the 11th World Congress of the International Neuromodulation Society.

12 Jun 2013

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.

12 Jun 2013

Low- and middle-income countries do too little to prevent chronic diseases

Nine years ago, the World Health Organization adopted a global strategy to address risk factors for chronic diseases such as heart disease, cancer and diabetes. Today, only a few low-and middle-income countries have implemented robust national policies to help prevent such non-communicable diseases, according to an international study led by the Institute of Tropical Medicine in Antwerp in collaboration with Ghent University, published in this week's PLOS Medicine.

12 Jun 2013

Study provides complete health picture of adult survivors of childhood cancer

St. Jude Children's Research Hospital has found that childhood cancer survivors overwhelmingly experience a significant amount of undiagnosed, serious disease through their adult years, establishing the importance of proactive, life-long clinical health screenings for this growing high-risk population.

12 Jun 2013

Study highlights positive and negative effects of peer support in chronic illness

Health organisations need to give careful consideration to schemes which encourage people with chronic diseases to seek support from peers, to avoid the potential negative effects, new research shows.

12 Jun 2013

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

Telephone-based counseling, when combined with physician advice, can help breast cancer survivors become more physically active, which can improve quality of life and lessen the side effects of cancer treatment, according to new research from The Miriam Hospital.

12 Jun 2013

Clinical trial underway for potential new treatment for type 1 diabetes

A clinical trial is underway for a potential new treatment for type 1 diabetes that could eventually mean patients are able to reduce insulin treatment from several times a day to only once or twice a week. The new treatment is a direct result of research to understand the genetics of the disease.

11 Jun 2013

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Cerus Corporation announced today that it has initiated patient enrollment in two European Phase III clinical trials for the INTERCEPT System for red blood cells.

11 Jun 2013

Study shows iron-uptake receptor plays a role in HCV infection

Hepatitis C virus (HCV) infects more than 170 million people worldwide. Approximately 80 percent of infections lead to chronic illness including fibrosis, cirrhosis, cancer and also hepatic iron overload.

11 Jun 2013

Brandeis University professor receives 2013 Neuroscience Prize for pioneering contributions in neural circuits

Eve Marder, PhD, a professor of neuroscience at Brandeis University, is the recipient of the 2013 Neuroscience Prize of The Gruber Foundation. Marder is being honored with this prestigious international award for her pioneering contributions to the understanding of neural circuits, particularly how the properties and dynamics of neural circuits give rise to specific behaviors.

11 Jun 2013

Rapamycin improves cardiac function in mice suffering from age-related heart disease

Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.

11 Jun 2013

Novel approach to pain therapy paves way for lower dosage painkillers

For patients managing cancer and other chronic health issues, painkillers such as morphine and Vicodin are often essential for pain relief. The body's natural tendency to develop tolerance to these medications, however, often requires patients to take higher doses - increasing risks of harmful side effects and dependency.

11 Jun 2013

3Care Therapeutics releases simplified nutritional program to improve patients' health

3Care Therapeutics, a manufacturer of nutritional supplements for treating common chronic health problems, announces the release of the 3Care BioSystems Program, a simplified nutritional program that helps practitioners improve patients' health and achieve thriving nutrition practices. The Program is administered via a free, easy-to-use software application; and unlike more complicated therapeutic lifestyle change programs, the 3Care Program encourages improved health outcomes through better patient compliance.

11 Jun 2013

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Researchers at Moffitt Cancer Center have determined that chronic myeloid leukemia patients who are treated with a class of oral chemotherapy drugs known as a tyrosine kinase inhibitors have significant side effects and quality-of-life issues that need to be addressed. Some of these issues include depression, fatigue, nausea and change of appearance.

11 Jun 2013

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.

10 Jun 2013

Concert Pharmaceuticals announces initiation of CTP-354 Phase 1 trial in healthy volunteers

Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.

10 Jun 2013

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1

10 Jun 2013

First consensus guidelines for use of neurostimulation in chronic pain

Recognizing that treatment of chronic pain can be confounding, the Neuromodulation Appropriateness Consensus Committee, an international group of more than 60 leading pain specialists, has created the first consensus guidelines for the use of neurostimulation in chronic pain.

10 Jun 2013

International experts formulate guidance for neuromodulation practitioners

An international panel of experts has formulated guidance for neuromodulation practitioners that reflects increasing recognition of the value of this growing field.

10 Jun 2013

Essential fatty acid found in vegetable oils does not promote inflammation in humans, scientists find

A typical American consumes approximately 3 or more tablespoons of vegetable oil each day. Vegetable oils, like those from soy, corn and canola, are a significant source of calories and are rich in linoleic acid, which is an essential nutrient.

10 Jun 2013

Chronic News and Research

Home treatment improves chronic constipation in children

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Low- and middle-income countries do too little to prevent chronic diseases

Study provides complete health picture of adult survivors of childhood cancer

Study highlights positive and negative effects of peer support in chronic illness

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

Clinical trial underway for potential new treatment for type 1 diabetes

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Study shows iron-uptake receptor plays a role in HCV infection

Brandeis University professor receives 2013 Neuroscience Prize for pioneering contributions in neural circuits

Rapamycin improves cardiac function in mice suffering from age-related heart disease

Novel approach to pain therapy paves way for lower dosage painkillers

3Care Therapeutics releases simplified nutritional program to improve patients' health

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

Concert Pharmaceuticals announces initiation of CTP-354 Phase 1 trial in healthy volunteers

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

First consensus guidelines for use of neurostimulation in chronic pain

International experts formulate guidance for neuromodulation practitioners

Essential fatty acid found in vegetable oils does not promote inflammation in humans, scientists find

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News